Advertisement

Topics

FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up

01:08 EST 14 Nov 2017 | RTTNews

Schizophrenia drug Abilify MyCite becomes the first drug approved in the U.S. with a sensor that digitally tracks if patients have ingested their medication. The U.S. Food and Drug Administration on Monday approved Abilify MyCite (aripiprazole tablets with sensor), developed by Otsuka Pharmaceutical Co., Ltd. In Japan, Otsuka Holdings' shares were gaining around 2.7 percent

Original Article: FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Pill With Sensor Abilify MyCite; Otsuka Stock Up"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Schizophrenia
Schizophrenia is a common  serious long-term mental health condition that affects 5 in 1000 in the UK. It causes a range of different psychological symptoms; hallucinations, delusions, muddled thoughts based on the hallucinations or delusions and ch...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...